Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- CheckyesterdayChange DetectedA new revision stamp, v3.6.1, was added to the history, replacing the previous v3.6.0 entry. This reflects a newer version of the study record being published in the history log.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a note that recruitment is no longer open to participants, and the record now shows a new revision tag v3.6.0 while removing the previous v3.5.5 tag.SummaryDifference0.3%

- Check22 days agoChange DetectedThe history list now shows a new revision entry v3.5.5, with the previous v3.5.4 removed from the visible history. This change represents an update to the page's revision metadata rather than substantive changes to the study content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history now shows a new Revision: v3.5.4 entry, replacing the previous Revision: v3.5.3. This represents a system version update to the page's history interface and does not alter the underlying study content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record version was updated to v3.5.3, replacing the previous v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdated the site revision/version indicator from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.